Weisblum Eric
SEC CIK 1569077 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SILO | Silo Pharma, Inc. | CEO, Pres, Dir | 214.4K | $68.6K | — | 21 | 2021-12-10 | 2025-12-15 |
Most active insiders at SILO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Weisblum Eric | CEO, Dir | $7,660 | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-16 | 2025-12-15 | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Dir | P - Purchase | $0.415 | +5,000 | 214.4K | +2% | +$2,075 |
| M | 2025-11-21 | 2025-11-20+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Dir | P - Purchase | $0.37 | +2,000 | 211.9K | +1.0% | +$740 |
| M | 2025-11-20 | 2025-11-18+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Dir | P - Purchase | $0.4037 | +12.0K | 205.4K | +6% | +$4,845 |
| 2025-05-28 | 2025-05-27 | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Dir | P - Purchase | $0.43 | +10.0K | 197.9K | +5% | +$4,300 | |
| 2024-12-16 | 2024-12-13 | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $0.84 | +2,500 | 187.9K | +1% | +$2,100 | |
| M | 2024-11-22 | 2024-11-20+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $0.925 | +5,000 | 182.9K | +3% | +$4,625 |
| M | 2024-06-13 | 2024-06-11+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.11 | +5,000 | 176.0K | +3% | +$5,533 |
| M | 2024-04-08 | 2024-04-04+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.99 | +1,000 | 175.0K | +0.6% | +$1,988 |
| M | 2024-04-01 | 2024-03-28+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.93 | +4,508 | 174.4K | +3% | +$8,713 |
| M | 2023-12-21 | 2023-12-19+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.62 | +700 | 169.9K | +0.4% | +$1,137 |
| M | 2023-12-18 | 2023-12-14+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.52 | +1,100 | 169.2K | +0.7% | +$1,668 |
| M | 2023-12-07 | 2023-12-05+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.38 | +1,000 | 168.1K | +0.6% | +$1,376 |
| M | 2023-11-30 | 2023-11-29+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.55 | +2,000 | 166.1K | +1% | +$3,100 |
| M | 2023-11-27 | 2023-11-22+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.72 | +650 | 165.1K | +0.4% | +$1,117 |
| M | 2023-11-22 | 2023-11-20+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.60 | +4,350 | 164.5K | +3% | +$6,948 |
| M | 2023-11-20 | 2023-11-16+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $1.46 | +2,900 | 158.3K | +2% | +$4,235 |
| M | 2023-05-18 | 2023-05-17+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $2.07 | +3,000 | 157.2K | +2% | +$6,205 |
| M | 2022-12-20 | 2022-12-19+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $2.70 | +330 | 154.9K | +0.2% | +$889.60 |
| M | 2022-12-15 | 2022-12-13+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $3.11 | +750 | 154.5K | +0.5% | +$2,329 |
| 2022-06-21 | 2022-06-17 | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, CFO, Pres, Dir | P - Purchase | $0.11 | +13.1K | 7.72M | +0.2% | +$1,439 | |
| M | 2021-12-15 | 2021-12-10+ | SILO | Silo Pharma, Inc. | Weisblum Eric | CEO, Dir | P - Purchase | $0.1444 | +22.5K | 7.71M | +0.3% | +$3,250 |
Purchase Sale Sale after option exercise All abbreviations